Mathes Company, Inc. Pfizer Inc Transaction History

Mathes Company, Inc.

$270 Million
Q2 2025

A detailed history of Mathes Company, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Mathes Company, Inc. holds 39,873 shares of PFE stock, worth $1.09 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

39,873

Previous 30,373 31.28%

Holding current value

$1.09 Million

Previous $770,000 25.58%

% of portfolio

0.36%

Previous 0.31%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	BUY	$21.59 - $24.84 $205,105 - $235,980	9,500 Added 31.28%	39,873 $967,000
Q1 2025 May 01, 2025	SELL	$25.01 - $27.13 $25,010 - $27,130	-1,000 Reduced 3.19%	30,373 $770,000
Q4 2024 Jan 31, 2025	SELL	$24.8 - $30.19 $137,069 - $166,860	-5,527 Reduced 14.98%	31,373 $832,000
Q3 2024 Oct 29, 2024	BUY	$27.7 - $31.39 $127,420 - $144,394	4,600 Added 14.24%	36,900 $1.07 Million
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $131,352 - $153,920	-5,200 Reduced 13.87%	32,300 $904,000
Q1 2024 May 02, 2024	BUY	$25.89 - $29.73 $157,929 - $181,353	6,100 Added 19.43%	37,500 $1.04 Million
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $45,150 - $52,237	-1,250 Reduced 3.83%	31,400 $1.15 Million
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $32,820 - $40,065	-750 Reduced 2.25%	32,650 $1.43 Million
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $53,716 - $79,625	1,300 Added 4.05%	33,400 $1.97 Million
Q2 2021 Jul 20, 2021	BUY	$35.91 - $40.68 $351,917 - $398,664	9,800 Added 43.95%	32,100 $1.26 Million
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $102,144 - $115,198	3,050 Added 15.84%	22,300 $808,000
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $6,694 - $8,512	200 Added 1.05%	19,250 $709,000
Q3 2020 Oct 26, 2020	BUY	$31.75 - $37.25 $334,962 - $392,987	10,550 Added 124.12%	19,050 $699,000
Q1 2020 Apr 21, 2020	SELL	$27.03 - $38.62 $121,635 - $173,790	-4,500 Reduced 34.62%	8,500 $277,000
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $148,140 - $168,120	-4,500 Reduced 25.71%	13,000 $509,000
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $115,410 - $131,580	-3,000 Reduced 14.63%	17,500 $764,000
Q3 2018 Oct 31, 2018	SELL	$34.47 - $41.81 $20,682 - $25,086	-600 Reduced 2.84%	20,500 $903,000
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $9,893 - $10,547	-300 Reduced 1.4%	21,100 $766,000
Q4 2017 Jan 19, 2018	SELL	$33.26 - $35.29 $372,512 - $395,248	-11,200 Reduced 34.36%	21,400 $775,000
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $1.01 Million - $1.11 Million	32,600	32,600 $1.16 Million

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mathes Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mathes Company, Inc. with notifications on news.

Account

Mathes Company, Inc. Pfizer Inc Transaction History